JP2008536815A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008536815A5 JP2008536815A5 JP2008501999A JP2008501999A JP2008536815A5 JP 2008536815 A5 JP2008536815 A5 JP 2008536815A5 JP 2008501999 A JP2008501999 A JP 2008501999A JP 2008501999 A JP2008501999 A JP 2008501999A JP 2008536815 A5 JP2008536815 A5 JP 2008536815A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- thioether bridge
- population
- cysteine residue
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66172405P | 2005-03-14 | 2005-03-14 | |
| US69913805P | 2005-07-13 | 2005-07-13 | |
| PCT/US2006/009311 WO2006099481A2 (en) | 2005-03-14 | 2006-03-14 | Macromolecules comprising a thioether cross-link |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008536815A JP2008536815A (ja) | 2008-09-11 |
| JP2008536815A5 true JP2008536815A5 (https=) | 2009-05-21 |
Family
ID=36992404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008501999A Abandoned JP2008536815A (ja) | 2005-03-14 | 2006-03-14 | チオエーテル架橋を含む巨大分子 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20090030187A1 (https=) |
| EP (1) | EP1858911A4 (https=) |
| JP (1) | JP2008536815A (https=) |
| AU (1) | AU2006223002A1 (https=) |
| CA (1) | CA2600844A1 (https=) |
| WO (1) | WO2006099481A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007245164A1 (en) * | 2006-03-28 | 2007-11-08 | Biogen Idec Ma Inc. | Anti-IGF-IR antibodies and uses thereof |
| KR20100052545A (ko) * | 2007-08-28 | 2010-05-19 | 바이오겐 아이덱 엠에이 인코포레이티드 | Ｉｇｆ―１ｒ의 다중 에피토프에 결합하는 조성물 |
| CA2697612A1 (en) * | 2007-08-28 | 2009-03-12 | Biogen Idec Ma Inc. | Anti-igf-1r antibodies and uses thereof |
| BRPI0816094A2 (pt) | 2007-08-30 | 2015-03-03 | Daiichi Sankyo Co Ltd | Anticorpo, polipeptídeo, hibridoma, composição farmacêutica, método para inibir o desenvolvimento de tumor em um mamífero, polinucleotídeo, célula hospedeira, e, método para produzir um anticorpo. |
| JP5615181B2 (ja) | 2007-11-27 | 2014-10-29 | ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア | 関節炎の予防及び治療のための組成物及び方法 |
| CN102065895A (zh) * | 2008-04-11 | 2011-05-18 | 比奥根艾迪克Ma公司 | 抗-igf-1r抗体和其它化合物的治疗联合 |
| AU2013337346A1 (en) * | 2012-11-05 | 2015-05-14 | Medimmune, Llc | Method of isolating Synagis in the absence of benzonase |
| BR112017008383A2 (en) * | 2014-10-31 | 2018-07-31 | Medimmune, Llc | improved production method |
| EP3420362B1 (en) * | 2016-02-25 | 2023-03-22 | The Binding Site Group Limited | Antibodies |
| GB201603291D0 (en) * | 2016-02-25 | 2016-04-13 | Binding Site Group The Ltd | Antibodies |
| US11479600B2 (en) | 2016-10-21 | 2022-10-25 | Adimab, Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| AU2017345786B2 (en) | 2016-10-21 | 2024-08-01 | Adimab, Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| CN110035771B (zh) | 2016-10-21 | 2024-03-08 | 阿迪马布有限责任公司 | 抗呼吸道合胞病毒抗体及其产生和使用方法 |
| GB201708262D0 (en) | 2017-05-23 | 2017-07-05 | Binding Site Group Ltd | Assay for plasma cell associated disease |
| CN108017717B (zh) * | 2018-01-24 | 2019-08-16 | 首都医科大学宣武医院 | 一种用于体外高效定向扩增的嵌合抗原受体及其应用 |
| JP7842564B2 (ja) * | 2018-09-21 | 2026-04-08 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | 粘液を透過するのを制限するための合成結合剤 |
| GB202007047D0 (en) | 2020-05-13 | 2020-06-24 | Binding Site Group Ltd | Mass spectrometry controls |
| WO2022175728A1 (en) * | 2021-02-19 | 2022-08-25 | Waters Technologies Corporation | Methods for peptide mapping of adeno-associated virus (aav) proteins |
| WO2025104604A1 (en) | 2023-11-14 | 2025-05-22 | Janssen Pharmaceuticals, Inc. | Anti-respiratory syncytial virus antibodies and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991003493A1 (en) | 1989-08-29 | 1991-03-21 | The University Of Southampton | Bi-or trispecific (fab)3 or (fab)4 conjugates |
| US5091542A (en) | 1990-03-09 | 1992-02-25 | Hybritech Incorporated | Tris-maleimido compounds as intermediates in trifunctional antibody synthesis |
| EP0597997B1 (en) * | 1991-08-09 | 1998-05-20 | KOLBECK, Winfried | Lanthionine bridged peptides |
| US6897044B1 (en) | 1999-01-28 | 2005-05-24 | Biogen Idec, Inc. | Production of tetravalent antibodies |
| KR100699059B1 (ko) * | 1999-04-23 | 2007-03-23 | 미쯔비시 가가꾸 가부시끼가이샤 | 항체 및 폴리알킬렌글리콜 결합 리포좀 |
| US20060123504A1 (en) * | 2004-12-07 | 2006-06-08 | Avigenics, Inc. | Methods of producing polyclonal antibodies |
| US20060286548A1 (en) * | 2005-06-16 | 2006-12-21 | Gregory Liposky | Method of making recombinant human antibodies for use in biosensor technology |
-
2006
- 2006-03-14 US US11/908,601 patent/US20090030187A1/en not_active Abandoned
- 2006-03-14 EP EP06738376A patent/EP1858911A4/en not_active Withdrawn
- 2006-03-14 CA CA002600844A patent/CA2600844A1/en not_active Abandoned
- 2006-03-14 WO PCT/US2006/009311 patent/WO2006099481A2/en not_active Ceased
- 2006-03-14 JP JP2008501999A patent/JP2008536815A/ja not_active Abandoned
- 2006-03-14 AU AU2006223002A patent/AU2006223002A1/en not_active Abandoned
- 2006-03-14 US US11/375,810 patent/US7786273B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008536815A5 (https=) | ||
| HRP20230338T1 (hr) | Anti-sars-cov-2-spike-glikoprotein antitijela i fragmenti za vezivanje antigena | |
| CY1121424T1 (el) | Αντισωματα εναντι toy tgfbeta | |
| HRP20090517T1 (hr) | Protutijela na interleukin-10 | |
| JP2022553324A5 (https=) | ||
| PE20110225A1 (es) | Composiciones y metodos para anticuerpos que se dirigen a la proteina de complemento c5 | |
| JP2020508655A5 (https=) | ||
| UA86605C2 (ru) | Антитело, которое содержит вариант исходного человеческого fс-участка | |
| EA200700136A1 (ru) | Анти-cd154-антитела | |
| RU2019121086A (ru) | Иммунотерапия с применением антител, связывающих лиганд 1 белка программируемой смерти клеток (PD-L1) | |
| JP2020524510A5 (https=) | ||
| MX2009012319A (es) | Polipeptidos que se unen a receptores fc con funciones efectoras modificadas. | |
| JP2022545682A5 (https=) | ||
| JP2008529529A5 (https=) | ||
| JP2005510246A5 (https=) | ||
| JP2016531546A5 (https=) | ||
| JP2015510875A (ja) | 分泌様免疫グロブリンを含む組成物 | |
| JP2023520969A5 (https=) | ||
| RU2019121106A (ru) | Иммунотерапия с применением антител, связывающих белок 1 программируемой смерти клеток (pd-1) | |
| FI4031569T3 (fi) | Kantasolutekijän vasta-aineet ja niiden käyttömenetelmät | |
| TWI857999B (zh) | 截斷的多價多元體 | |
| JP2024546763A5 (https=) | ||
| AU2020414409A1 (en) | Method for the production of bispecific FcyRIIl x CD30 antibody construct | |
| Shigenori et al. | Hinge region of human IgG2 protein: conformational studies with monoclonal antibodies | |
| JP2022517865A5 (https=) |